Immunochemistry Market In Americas 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	160 Pages	TechNavio	May, 2024	INF18930409

Best Price Guarantee
Price	from $2,500
Length	160 Pages
Publisher	TechNavio
Published Date	May, 2024
SKU	INF18930409

Global Immunochemistry Market In Americas 2024-2028

The immunochemistry market in americas is forecasted to grow by USD 3621.75 mn during 2023-2028, accelerating at a CAGR of 6.98% during the forecast period. The report on the immunochemistry market in americas provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, increasing incidences of neurological disorders, and technological advances in antibody manufacturing.

Technavio's immunochemistry market in americas is segmented as below:

By Product

Consumables
Equipment

By Application

Infectious disease
Cardiology
Oncology
Autoimmune disease
Nephrology and others

By Geographical Landscape

Americas

This study identifies the rising new product launches as one of the prime reasons driving the immunochemistry market in americas growth during the next few years. Also, increasing number of clinical trials and emergence of new disease targets will lead to sizable demand in the market.

The report on the immunochemistry market in americas covers the following areas:

Immunochemistry market in americas sizing
Immunochemistry market in americas forecast
Immunochemistry market in americas industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunochemistry market in americas vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., bioMerieux SA, Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Grifols SA, Hologic Inc., Merck and Co. Inc., Mindray Bio medical Electronics Co. Ltd., PerkinElmer Inc., Quanterix Corp., Randox Laboratories Ltd., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Tosoh Corp.. Also, the immunochemistry market in americas analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Country Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Product; Exhibit 06: Executive Summary - Chart on Market Segmentation by Application; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Americas - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Regional - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Americas: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
4 Historic Market Size: 4.1 Immunochemistry market in Americas 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on immunochemistry market in Americas 2018 - 2022 ($ million); 4.2 Product Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.3 Application Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 22: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 23: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 25: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 26: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 27: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 28: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Exhibit 29: Chart on Product - Market share 2023-2028 (%); Exhibit 30: Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Exhibit 31: Chart on Comparison by Product; Exhibit 32: Data Table on Comparison by Product; 6.3 Consumables - Market size and forecast 2023-2028; Exhibit 33: Chart on Consumables - Market size and forecast 2023-2028 ($ million); Exhibit 34: Data Table on Consumables - Market size and forecast 2023-2028 ($ million); Exhibit 35: Chart on Consumables - Year-over-year growth 2023-2028 (%); Exhibit 36: Data Table on Consumables - Year-over-year growth 2023-2028 (%); 6.4 Equipment - Market size and forecast 2023-2028; Exhibit 37: Chart on Equipment - Market size and forecast 2023-2028 ($ million); Exhibit 38: Data Table on Equipment - Market size and forecast 2023-2028 ($ million); Exhibit 39: Chart on Equipment - Year-over-year growth 2023-2028 (%); Exhibit 40: Data Table on Equipment - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Product; Exhibit 41: Market opportunity by Product ($ million); Exhibit 42: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Exhibit 43: Chart on Application - Market share 2023-2028 (%); Exhibit 44: Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Exhibit 45: Chart on Comparison by Application; Exhibit 46: Data Table on Comparison by Application; 7.3 Infectious disease - Market size and forecast 2023-2028; Exhibit 47: Chart on Infectious disease - Market size and forecast 2023-2028 ($ million); Exhibit 48: Data Table on Infectious disease - Market size and forecast 2023-2028 ($ million); Exhibit 49: Chart on Infectious disease - Year-over-year growth 2023-2028 (%); Exhibit 50: Data Table on Infectious disease - Year-over-year growth 2023-2028 (%); 7.4 Cardiology - Market size and forecast 2023-2028; Exhibit 51: Chart on Cardiology - Market size and forecast 2023-2028 ($ million); Exhibit 52: Data Table on Cardiology - Market size and forecast 2023-2028 ($ million); Exhibit 53: Chart on Cardiology - Year-over-year growth 2023-2028 (%); Exhibit 54: Data Table on Cardiology - Year-over-year growth 2023-2028 (%); 7.5 Oncology - Market size and forecast 2023-2028; Exhibit 55: Chart on Oncology - Market size and forecast 2023-2028 ($ million); Exhibit 56: Data Table on Oncology - Market size and forecast 2023-2028 ($ million); Exhibit 57: Chart on Oncology - Year-over-year growth 2023-2028 (%); Exhibit 58: Data Table on Oncology - Year-over-year growth 2023-2028 (%); 7.6 Autoimmune disease - Market size and forecast 2023-2028; Exhibit 59: Chart on Autoimmune disease - Market size and forecast 2023-2028 ($ million); Exhibit 60: Data Table on Autoimmune disease - Market size and forecast 2023-2028 ($ million); Exhibit 61: Chart on Autoimmune disease - Year-over-year growth 2023-2028 (%); Exhibit 62: Data Table on Autoimmune disease - Year-over-year growth 2023-2028 (%); 7.7 Nephrology and others - Market size and forecast 2023-2028; Exhibit 63: Chart on Nephrology and others - Market size and forecast 2023-2028 ($ million); Exhibit 64: Data Table on Nephrology and others - Market size and forecast 2023-2028 ($ million); Exhibit 65: Chart on Nephrology and others - Year-over-year growth 2023-2028 (%); Exhibit 66: Data Table on Nephrology and others - Year-over-year growth 2023-2028 (%); 7.8 Market opportunity by Application; Exhibit 67: Market opportunity by Application ($ million); Exhibit 68: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 70: Chart on Market share By Geographical Landscape - 2023-2028 (%); Exhibit 71: Data Table on Market share By Geographical Landscape - 2023-2028 (%); 9.2 Geographic comparison; Exhibit 72: Chart on Geographic comparison; Exhibit 73: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 74: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 75: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 76: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 77: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 South America - Market size and forecast 2023-2028; Exhibit 78: Chart on South America - Market size and forecast 2023-2028 ($ million); Exhibit 79: Data Table on South America - Market size and forecast 2023-2028 ($ million); Exhibit 80: Chart on South America - Year-over-year growth 2023-2028 (%); Exhibit 81: Data Table on South America - Year-over-year growth 2023-2028 (%); 9.5 Market opportunity By Geographical Landscape; Exhibit 82: Market opportunity By Geographical Landscape ($ million); Exhibit 83: Data Table on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 84: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 85: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 86: Overview on factors of disruption; 11.4 Industry risks; Exhibit 87: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 88: Vendors covered; 12.2 Market positioning of vendors; Exhibit 89: Matrix on vendor position and classification; 12.3 Abbott Laboratories; Exhibit 90: Abbott Laboratories - Overview; Exhibit 91: Abbott Laboratories - Business segments; Exhibit 92: Abbott Laboratories - Key news; Exhibit 93: Abbott Laboratories - Key offerings; Exhibit 94: Abbott Laboratories - Segment focus; 12.4 Agilent Technologies Inc.; Exhibit 95: Agilent Technologies Inc. - Overview; Exhibit 96: Agilent Technologies Inc. - Business segments; Exhibit 97: Agilent Technologies Inc. - Key news; Exhibit 98: Agilent Technologies Inc. - Key offerings; Exhibit 99: Agilent Technologies Inc. - Segment focus; 12.5 Becton Dickinson and Co.; Exhibit 100: Becton Dickinson and Co. - Overview; Exhibit 101: Becton Dickinson and Co. - Business segments; Exhibit 102: Becton Dickinson and Co. - Key offerings; Exhibit 103: Becton Dickinson and Co. - Segment focus; 12.6 Bio Rad Laboratories Inc.; Exhibit 104: Bio Rad Laboratories Inc. - Overview; Exhibit 105: Bio Rad Laboratories Inc. - Business segments; Exhibit 106: Bio Rad Laboratories Inc. - Key news; Exhibit 107: Bio Rad Laboratories Inc. - Key offerings; Exhibit 108: Bio Rad Laboratories Inc. - Segment focus; 12.7 Bio Techne Corp.; Exhibit 109: Bio Techne Corp. - Overview; Exhibit 110: Bio Techne Corp. - Business segments; Exhibit 111: Bio Techne Corp. - Key offerings; Exhibit 112: Bio Techne Corp. - Segment focus; 12.8 Danaher Corp.; Exhibit 113: Danaher Corp. - Overview; Exhibit 114: Danaher Corp. - Business segments; Exhibit 115: Danaher Corp. - Key news; Exhibit 116: Danaher Corp. - Key offerings; Exhibit 117: Danaher Corp. - Segment focus; 12.9 DiaSorin SpA; Exhibit 118: DiaSorin SpA - Overview; Exhibit 119: DiaSorin SpA - Business segments; Exhibit 120: DiaSorin SpA - Key offerings; Exhibit 121: DiaSorin SpA - Segment focus; 12.10 F. Hoffmann La Roche Ltd.; Exhibit 122: F. Hoffmann La Roche Ltd. - Overview; Exhibit 123: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 124: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 125: F. Hoffmann La Roche Ltd. - Segment focus; 12.11 Fujirebio Holdings Inc.; Exhibit 126: Fujirebio Holdings Inc. - Overview; Exhibit 127: Fujirebio Holdings Inc. - Product / Service; Exhibit 128: Fujirebio Holdings Inc. - Key offerings; 12.12 Merck and Co. Inc.; Exhibit 129: Merck and Co. Inc. - Overview; Exhibit 130: Merck and Co. Inc. - Business segments; Exhibit 131: Merck and Co. Inc. - Key news; Exhibit 132: Merck and Co. Inc. - Key offerings; Exhibit 133: Merck and Co. Inc. - Segment focus; 12.13 Quanterix Corp.; Exhibit 134: Quanterix Corp. - Overview; Exhibit 135: Quanterix Corp. - Product / Service; Exhibit 136: Quanterix Corp. - Key offerings; 12.14 Randox Laboratories Ltd.; Exhibit 137: Randox Laboratories Ltd. - Overview; Exhibit 138: Randox Laboratories Ltd. - Key offerings; 12.15 Siemens AG; Exhibit 139: Siemens AG - Overview; Exhibit 140: Siemens AG - Business segments; Exhibit 141: Siemens AG - Key news; Exhibit 142: Siemens AG - Key offerings; Exhibit 143: Siemens AG - Segment focus; 12.16 Sysmex Corp.; Exhibit 144: Sysmex Corp. - Overview; Exhibit 145: Sysmex Corp. - Business segments; Exhibit 146: Sysmex Corp. - Key offerings; Exhibit 147: Sysmex Corp. - Segment focus; 12.17 Thermo Fisher Scientific Inc.; Exhibit 148: Thermo Fisher Scientific Inc. - Overview; Exhibit 149: Thermo Fisher Scientific Inc. - Business segments; Exhibit 150: Thermo Fisher Scientific Inc. - Key news; Exhibit 151: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 152: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 153: Inclusions checklist; Exhibit 154: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 155: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 156: Research methodology; Exhibit 157: Validation techniques employed for market sizing; Exhibit 158: Information sources; 13.5 List of abbreviations; Exhibit 159: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Americas - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Regional - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Americas: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Regional - Market size and forecast 2023-2028 ($ million); Exhibits18: Historic Market Size - Data Table on immunochemistry market in Americas 2018 - 2022 ($ million); Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Five forces analysis - Comparison between 2023 and 2028; Exhibits23: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits25: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits26: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits27: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits28: Chart on Market condition - Five forces 2023 and 2028; Exhibits29: Chart on Product - Market share 2023-2028 (%); Exhibits30: Data Table on Product - Market share 2023-2028 (%); Exhibits31: Chart on Comparison by Product; Exhibits32: Data Table on Comparison by Product; Exhibits33: Chart on Consumables - Market size and forecast 2023-2028 ($ million); Exhibits34: Data Table on Consumables - Market size and forecast 2023-2028 ($ million); Exhibits35: Chart on Consumables - Year-over-year growth 2023-2028 (%); Exhibits36: Data Table on Consumables - Year-over-year growth 2023-2028 (%); Exhibits37: Chart on Equipment - Market size and forecast 2023-2028 ($ million); Exhibits38: Data Table on Equipment - Market size and forecast 2023-2028 ($ million); Exhibits39: Chart on Equipment - Year-over-year growth 2023-2028 (%); Exhibits40: Data Table on Equipment - Year-over-year growth 2023-2028 (%); Exhibits41: Market opportunity by Product ($ million); Exhibits42: Data Table on Market opportunity by Product ($ million); Exhibits43: Chart on Application - Market share 2023-2028 (%); Exhibits44: Data Table on Application - Market share 2023-2028 (%); Exhibits45: Chart on Comparison by Application; Exhibits46: Data Table on Comparison by Application; Exhibits47: Chart on Infectious disease - Market size and forecast 2023-2028 ($ million); Exhibits48: Data Table on Infectious disease - Market size and forecast 2023-2028 ($ million); Exhibits49: Chart on Infectious disease - Year-over-year growth 2023-2028 (%); Exhibits50: Data Table on Infectious disease - Year-over-year growth 2023-2028 (%); Exhibits51: Chart on Cardiology - Market size and forecast 2023-2028 ($ million); Exhibits52: Data Table on Cardiology - Market size and forecast 2023-2028 ($ million); Exhibits53: Chart on Cardiology - Year-over-year growth 2023-2028 (%); Exhibits54: Data Table on Cardiology - Year-over-year growth 2023-2028 (%); Exhibits55: Chart on Oncology - Market size and forecast 2023-2028 ($ million); Exhibits56: Data Table on Oncology - Market size and forecast 2023-2028 ($ million); Exhibits57: Chart on Oncology - Year-over-year growth 2023-2028 (%); Exhibits58: Data Table on Oncology - Year-over-year growth 2023-2028 (%); Exhibits59: Chart on Autoimmune disease - Market size and forecast 2023-2028 ($ million); Exhibits60: Data Table on Autoimmune disease - Market size and forecast 2023-2028 ($ million); Exhibits61: Chart on Autoimmune disease - Year-over-year growth 2023-2028 (%); Exhibits62: Data Table on Autoimmune disease - Year-over-year growth 2023-2028 (%); Exhibits63: Chart on Nephrology and others - Market size and forecast 2023-2028 ($ million); Exhibits64: Data Table on Nephrology and others - Market size and forecast 2023-2028 ($ million); Exhibits65: Chart on Nephrology and others - Year-over-year growth 2023-2028 (%); Exhibits66: Data Table on Nephrology and others - Year-over-year growth 2023-2028 (%); Exhibits67: Market opportunity by Application ($ million); Exhibits68: Data Table on Market opportunity by Application ($ million); Exhibits69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits70: Chart on Market share By Geographical Landscape - 2023-2028 (%); Exhibits71: Data Table on Market share By Geographical Landscape - 2023-2028 (%); Exhibits72: Chart on Geographic comparison; Exhibits73: Data Table on Geographic comparison; Exhibits74: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits76: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits78: Chart on South America - Market size and forecast 2023-2028 ($ million); Exhibits79: Data Table on South America - Market size and forecast 2023-2028 ($ million); Exhibits80: Chart on South America - Year-over-year growth 2023-2028 (%); Exhibits81: Data Table on South America - Year-over-year growth 2023-2028 (%); Exhibits82: Market opportunity By Geographical Landscape ($ million); Exhibits83: Data Table on Market opportunity By Geographical Landscape ($ million); Exhibits84: Impact of drivers and challenges in 2023 and 2028; Exhibits85: Overview on Criticality of inputs and Factors of differentiation; Exhibits86: Overview on factors of disruption; Exhibits87: Impact of key risks on business; Exhibits88: Vendors covered; Exhibits89: Matrix on vendor position and classification; Exhibits90: Abbott Laboratories - Overview; Exhibits91: Abbott Laboratories - Business segments; Exhibits92: Abbott Laboratories - Key news; Exhibits93: Abbott Laboratories - Key offerings; Exhibits94: Abbott Laboratories - Segment focus; Exhibits95: Agilent Technologies Inc. - Overview; Exhibits96: Agilent Technologies Inc. - Business segments; Exhibits97: Agilent Technologies Inc. - Key news; Exhibits98: Agilent Technologies Inc. - Key offerings; Exhibits99: Agilent Technologies Inc. - Segment focus; Exhibits100: Becton Dickinson and Co. - Overview; Exhibits101: Becton Dickinson and Co. - Business segments; Exhibits102: Becton Dickinson and Co. - Key offerings; Exhibits103: Becton Dickinson and Co. - Segment focus; Exhibits104: Bio Rad Laboratories Inc. - Overview; Exhibits105: Bio Rad Laboratories Inc. - Business segments; Exhibits106: Bio Rad Laboratories Inc. - Key news; Exhibits107: Bio Rad Laboratories Inc. - Key offerings; Exhibits108: Bio Rad Laboratories Inc. - Segment focus; Exhibits109: Bio Techne Corp. - Overview; Exhibits110: Bio Techne Corp. - Business segments; Exhibits111: Bio Techne Corp. - Key offerings; Exhibits112: Bio Techne Corp. - Segment focus; Exhibits113: Danaher Corp. - Overview; Exhibits114: Danaher Corp. - Business segments; Exhibits115: Danaher Corp. - Key news; Exhibits116: Danaher Corp. - Key offerings; Exhibits117: Danaher Corp. - Segment focus; Exhibits118: DiaSorin SpA - Overview; Exhibits119: DiaSorin SpA - Business segments; Exhibits120: DiaSorin SpA - Key offerings; Exhibits121: DiaSorin SpA - Segment focus; Exhibits122: F. Hoffmann La Roche Ltd. - Overview; Exhibits123: F. Hoffmann La Roche Ltd. - Business segments; Exhibits124: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits125: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits126: Fujirebio Holdings Inc. - Overview; Exhibits127: Fujirebio Holdings Inc. - Product / Service; Exhibits128: Fujirebio Holdings Inc. - Key offerings; Exhibits129: Merck and Co. Inc. - Overview; Exhibits130: Merck and Co. Inc. - Business segments; Exhibits131: Merck and Co. Inc. - Key news; Exhibits132: Merck and Co. Inc. - Key offerings; Exhibits133: Merck and Co. Inc. - Segment focus; Exhibits134: Quanterix Corp. - Overview; Exhibits135: Quanterix Corp. - Product / Service; Exhibits136: Quanterix Corp. - Key offerings; Exhibits137: Randox Laboratories Ltd. - Overview; Exhibits138: Randox Laboratories Ltd. - Key offerings; Exhibits139: Siemens AG - Overview; Exhibits140: Siemens AG - Business segments; Exhibits141: Siemens AG - Key news; Exhibits142: Siemens AG - Key offerings; Exhibits143: Siemens AG - Segment focus; Exhibits144: Sysmex Corp. - Overview; Exhibits145: Sysmex Corp. - Business segments; Exhibits146: Sysmex Corp. - Key offerings; Exhibits147: Sysmex Corp. - Segment focus; Exhibits148: Thermo Fisher Scientific Inc. - Overview; Exhibits149: Thermo Fisher Scientific Inc. - Business segments; Exhibits150: Thermo Fisher Scientific Inc. - Key news; Exhibits151: Thermo Fisher Scientific Inc. - Key offerings; Exhibits152: Thermo Fisher Scientific Inc. - Segment focus; Exhibits153: Inclusions checklist; Exhibits154: Exclusions checklist; Exhibits155: Currency conversion rates for US$; Exhibits156: Research methodology; Exhibits157: Validation techniques employed for market sizing; Exhibits158: Information sources; Exhibits159: List of abbreviations